Structure-based drug design of RdRp inhibitors against SARS-CoV-2
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
Triazavirin—A novel effective antiviral drug
ON Chupakhin, VL Rusinov, MV Varaksin… - International Journal of …, 2022 - mdpi.com
This review outlines the data of numerous studies relating to the broad-spectrum antiviral
drug Triazavirin that was launched on the Russian pharmaceutical market in 2014 as an anti …
drug Triazavirin that was launched on the Russian pharmaceutical market in 2014 as an anti …
A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA‐dependent RNA polymerase of wild‐type and Delta …
The antiviral drug molnupiravir targets the SARS‐CoV‐2 RNA‐dependent RNA polymerase
(RdRP) enzyme. Early treatment with molnupiravir reduced the risk of hospitalization or …
(RdRP) enzyme. Early treatment with molnupiravir reduced the risk of hospitalization or …
[PDF][PDF] Beta Elemene induces cytotoxic effects in FLT3 ITD-mutated acute myeloid leukemia by modulating apoptosis.
Beta Elemene induces cytotoxic effects in FLT3 ITD-mutated acute myeloid leukemia by
modulating apoptosis Page 1 3270 Abstract. – OBJECTIVE: β-Elemene, a sesquiterpene with a …
modulating apoptosis Page 1 3270 Abstract. – OBJECTIVE: β-Elemene, a sesquiterpene with a …
[HTML][HTML] Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase
T Xu, L Zhang - Computational and Structural Biotechnology Journal, 2023 - Elsevier
Since the outbreak of the COVID-19 pandemic, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main …
coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main …
[HTML][HTML] Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
Z Wang, L Yang, XE Zhao - Computational and Structural Biotechnology …, 2021 - Elsevier
Safer and more-effective drugs are urgently needed to counter infections with the highly
pathogenic SARS-CoV-2, cause of the COVID-19 pandemic. Identification of efficient …
pathogenic SARS-CoV-2, cause of the COVID-19 pandemic. Identification of efficient …
Attenuation of quorum sensing regulated virulence functions and biofilm of pathogenic bacteria by medicinal plant Artemisia annua and its phytoconstituent 1, 8 …
The emergence of multidrug resistance (MDR) in bacterial pathogens is a serious public
health concern. A significant therapeutic target for MDR infections is the quorum sensing …
health concern. A significant therapeutic target for MDR infections is the quorum sensing …
Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound …
E Aleebrahim-Dehkordi, H Ghoshouni… - Journal of Molecular …, 2023 - Elsevier
The prevalence of SARS-CoV-2-induced respiratory infections is now a major challenge
worldwide. There is currently no specific antiviral drug to prevent or treat this disease …
worldwide. There is currently no specific antiviral drug to prevent or treat this disease …
Atypical mutational spectrum of SARS-CoV-2 replicating in the presence of ribavirin
We report that ribavirin exerts an inhibitory and mutagenic activity on SARS-CoV-2-infecting
Vero cells, with a therapeutic index higher than 10. Deep sequencing analysis of the mutant …
Vero cells, with a therapeutic index higher than 10. Deep sequencing analysis of the mutant …
Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin
Monoamine oxidases (MAOs) are attractive targets in drug design. The inhibition of one of
the isoforms (A or B) is responsible for modulating the levels of different neurotransmitters in …
the isoforms (A or B) is responsible for modulating the levels of different neurotransmitters in …